Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jolanta Lis-Kuberka has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Magdalena Orczyk-Pawiłowicz

    Division of Chemistry and Immunochemistry, Department of Biochemistry and Immunochemistry, Wroclaw Medical University, M. Skłodowskiej-Curie 48/50, 50-369 Wroclaw, Poland

    14 shared publications
  • Marta Berghausen-Mazur

    Department of Pediatrics, Division of Neonatology, Wroclaw Medical University, Bartla 5, 51-618 Wroclaw, Poland

    5 shared publications
  • Aleksandra Klimczak

    Laboratory of Biology of Stem and Neoplastic Cells, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wroclaw, Poland

    2 shared publications
  • Honorata Kraskiewicz

    Laboratory of Biology of Stem and Neoplastic Cells, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wroclaw, Poland

    2 shared publications
  • Magdalena Orczyk-Pawiłowicz

    Division of Chemistry and Immunochemistry, Department of Biochemistry and Immunochemistry, Wroclaw Medical University

    2 shared publications
  • Paulina Piotrowska

    Laboratory of Biology of Stem and Neoplastic Cells, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wroclaw, Poland

    2 shared publications

Latest Publications

  • Open Access

    Anti-Calcification Effects of Immortalized Human Adipose Tissue-Derived Mesenchymal Stem/Stromal Cell (HATMSC2) Secretome in an In Vitro Model of Vascular Calcification

    by Paulina Piotrowska, Honorata Kraskiewicz, Jolanta Lis-Kuberka, Aleksandra Klimczak

    Vascular calcification (VC) is a very common complication associated with aging, chronic kidney disease, diabetes, and atherosclerosis, predicting cardiovascular morbidity and mortality, but remains largely resistant to current therapies. This study investigated the anti-calcification properties of a secretome derived from a human adipose tissue-derived mesenchymal stem/stromal cell line (HATMSC2) using an in vitro model of vascular smooth muscle cell (VSMC) calcification. VSMCs were cultured in both inorganic and organic calcification media with or without HATMSC2 secretome supplementation (50 μg/mL). Calcium deposition was assessed with Alizarin Red S staining, while osteogenic markers (RUNX2, OPN, OSX, COL-1, OCN) and contractile marker α-SMA were evaluated with Western blot and RT-PCR. The HATMSC2 secretome significantly reduced calcium deposits and suppressed the upregulation of osteogenic markers in the organic calcification model, preventing osteogenic transdifferentiation. Furthermore, the secretome significantly decreased the adhesion of the THP-1 monocyte to VSMCs under calcification-promoting conditions, confirming its immunomodulatory effects. The detection of BMP antagonists, GREM1 and CHRDL1, MGP (anti-calcification factor), and the BMP signaling agonist BMP-7 in the HATMSC2-derived secretome indicates factors that may potentially contribute to its anti-calcification activity. These findings are consistent with the modulation of osteogenic signaling pathways; however, the precise molecular mechanisms and the individual contribution of the identified proteins require further functional validation.

  • Open Access

    Adiposity-dependent adipokine-immunoglobulin interplay in mature breast milk

    by Jolanta Lis-Kuberka, Magdalena Humaj-Grysztar, Anna Apanasewicz, Maja Matyas, Anna Ziomkiewicz, Magdalena Orczyk-Pawiłowicz

    Introduction: Excessive maternal body fat (BF) accumulation promotes low-grade inflammation, altering milk adipokine and immunoglobulin profiles and potentially contributing to intergenerational immunometabolic programming of offspring. This observational study focused on mothers with higher BF and evaluated associations between adipokines and immune components in mature milk. Methods: At 5 months of lactation (N = 59), concentrations of lactoferrin (LF), immunoglobulins (S-IgA, IgG, IgM), CRP, adipokines (leptin, adiponectin, and ghrelin), and the leptin-to-adiponectin ratio (LAR) were quantified in milk samples using an immunoenzymatic assay. ANCOVA models assessed associations between maternal BF categories (high vs normal) and milk adipokines and immunological components. Results: Mature milk from mothers with higher BF showed significantly higher concentrations of CRP (8.00 vs 3.44 μg/L), leptin (0.41 vs 0.14 μg/L), LAR (0.13 vs 0.05), and IgM (2.78 vs 1.59 mg/L) than the normal BF group. ANCOVA models revealed positive associations between milk leptin and LF (β=0.51, p = 0.022) and S-IgA (β=0.47, p = 0.014), as well as LAR and LF (β=0.37, p = 0.032). No significant differences in adiponectin, ghrelin, LF, S-IgA, or IgG concentrations were observed between the analyzed groups. Elevated maternal BF is associated with higher levels of breast milk inflammatory markers (CRP, leptin), LAR, and IgM, suggesting metabolically induced inflammation. Discussion: Leptin-immunoactive component associations (S-IgA, LF) offer novel insights into milk bioactivity. These findings highlight the role of metabolic-immunological milk components in shaping health trajectories for infants of mothers with elevated BF.

  • Open Access

    Gestational diabetes mellitus–induced adipokine dysregulation and links to metabolic programming risks

    by Jolanta Lis‐Kuberka, Marta Berghausen‐Mazur

    Introduction: Gestational diabetes mellitus (GDM) is a pregnancy−related hyperglycemic disorder with highly variable global prevalence, largely driven by differences in diagnostic criteria, maternal characteristics, and lifestyle factors, which complicates efforts to standardize screening and prevention. GDM disrupts maternal–fetal glucose homeostasis, leading to fetal exposure to hyperglycemia and hyperinsulinemia, and is associated not only with immediate obstetric complications but also with long−term metabolic risk in both mothers and offspring. Objective: This study evaluated the impact of maternal hyperglycemia, classified as diet−controlled (GDM−diet) or insulin−treated (GDM-insulin), on leptin, adiponectin, soluble leptin receptor (sLeptinR), and the derived indices leptin−to−adiponectin ratio (LAR) and free leptin index (FLI) across the maternal–fetal axis. Design: This study was a retrospective observational cohort study targeting patients with gestational diabetes mellitus. Maternal and cord blood plasma from 30 hyperglycemic and 23 normoglycemic mothers were analyzed for leptin, adiponectin, and soluble leptin receptor concentrations using immunoenzymatic assays. Results: Maternal plasma leptin concentrations were significantly higher in the GDM-insulin group (10.05 ng/mL) than in non-GDM pregnancies (4.44 ng/mL; p = 0.033). The leptin-to-adiponectin ratio was also elevated in GDM-insulin (4.99) compared to GDM-diet (2.18; p = 0.043). No significant between-group differences were observed for adiponectin, soluble leptin receptor, or the free leptin index. In cord blood, adiponectin concentrations were higher in GDM-diet neonates (9.05 μg/mL) than in GDM-insulin (5.70 μg/mL; p = 0.010). Maternal leptin and its derived indices (LAR, FLI) were associated with maternal overweight/obesity, whereas maternal adiponectin and cord blood leptin were related to neonatal birth weight. Conclusion: These findings point to leptin, adiponectin, FLI, and LAR as possible metabolic indicators of GDM-linked insulin resistance, and low-grade inflammation. Higher maternal leptin, LAR, and FLI, alongside stable sLeptinR, signal leptin resistance, which disrupts placental nutrient transport and links maternal metabolic stress to fetal anthropometric measures. Tracking these markers could guide postnatal steps to cut long-term metabolic risks across the next generations.


  • Open Access

    Prevention of Vascular Calcification via Fetuin-Modified Bioprosthetic Implants: Insights from in Vitro Models

    by Paulina Piotrowska, Ankit Mazumdar, Natalia Beshchasna, Bjoern Guenther, Roman Viter, Mindaugas Tamošiūnas, Iryna Tepliakova, Özlem Saröz Kirazli, Ahmet Altuğ Çinçin, Esin Ak, et al.

    Research into bioprosthetic heart valve (BHV) materials seeks to enhance durability and biocompatibility, particularly by mitigating vascular calcification (VC). VC entails hydroxyapatite deposition in blood vessel walls through vascular smooth muscle cells (VSMCs) phenotypic switching to osteogenic differentiation, driven by pro-calcific signals that might be inhibited by fetuin-A. To our knowledge, no prior studies have reported fetuin-coated bovine vein tissue for this purpose. This study aimed to evaluate the cytotoxicity, biocompatibility, and anti-calcification potential of fetuin-coated biomaterial. The effectiveness of fetuin coating on biomaterial was characterized using photoluminescence (PL), FTIR and Raman spectroscopy, while fetuin release was quantified. Biocompatibility was evaluated in vitro on VSMCs and human iliac artery endothelial cells (HIAE-78T) and in vivo by subcutaneous implantation in Wistar rats. The effects of fetuin were investigated in two in vitro calcification models based on 2 mM inorganic phosphate, or 10 mM β-glycerophosphate in an organic model. The induction of osteogenic markers such as osterix, bone morphogenic protein 2, and collagen type 1, osteocalcin and osteopontin, was assessed at both the mRNA and protein levels. Detoxification of glutaraldehyde-fixed biomaterial using glycine and NaBH₄ eliminated cytotoxicity, markedly enhancing biocompatibility toward VSMCs, HIAE-78T and subcutaneous rat implants, which showed no acute rejection and preserved structural integrity. Fetuin coating, with ~30% sustained release over three weeks, significantly inhibited mineralization on non-cellular and organic VSMCs models by decreasing mineral deposition, osteogenic markers expression. These results position fetuin-coated bovine vein biomaterial as a novel, promising anti-calcification strategy enhancing long-term durability and cardiac valves safety.

  • Open Access

    Lactoferrin and SIgA Concentrations in Human Milk of SARS-CoV–Infected Mothers—Polish Cohort Study

    by Aleksandra Mołas, Jolanta Lis-Kuberka, Agnieszka Bzikowska-Jura, Aleksandra Wesołowska, Tengchuan Jin, Maciej W. Socha, Magdalena Orczyk-Pawiłowicz

    Background: Human milk (HM) provides critical immunological support to neonates, serving as a key component of passive immunity during early life. Objectives: The main aim of this cohort study was to compare the concentrations of lactoferrin (Lf), secretory immunoglobulin A (SIgA), C-reactive protein (CRP), and their ratios to total protein levels in the colostrum of postpartum women infected with SARS-CoV-2 and healthy controls. Methods: Colostrum samples (3–5 mL) were collected from 40 mothers (20 infected, 20 healthy) during the first wave of the COVID-19 pandemic in Poland. Concentrations of Lf, SIgA, and CRP were analyzed using ELISA, and total protein content was measured using the bicinchoninic acid assay (BCA). Results: The presence of specific anti-SARS-CoV-2 SIgA antibodies was assessed via cassette serological lateral flow detection tests. Significant differences were observed in Lf (p = 0.04) and SIgA (p = 0.03) concentrations, both lower in the COVID-19 group. Lactoferrin medians were 12.30 g/L (infected) and 14.95 g/L (healthy), and for SIgA: 9.15 g/L vs. 15.01 g/L, respectively. No significant difference was found in CRP levels. Interestingly, the Lf/Protein ratio was significantly higher in the infected group (p = 0.03), whereas the SIgA/Protein ratio did not differ. Furthermore, 75% of infected mothers had positive anti-SARS-CoV-2 SIgA results. These mothers also showed a higher Lf/Protein ratio. Among healthy controls, 90% had negative test results. Conclusions: These findings suggest a potential compensatory role of lactoferrin in the nonspecific immune response to SARS-CoV-2, though stress-related reductions in SIgA levels cannot be excluded.


  • Open Access

    Maternal Vaccination and Neonatal Feeding Strategies Among Polish Women

    by Jolanta Lis-Kuberka, Magdalena Orczyk-Pawiłowicz

    Background/Objectives: Maternal vaccination and breastfeeding are important aspects of public health that should be recommended by medical staff caring for pregnant and postpartum women. We aimed to analyze factors affecting women’s likelihood of dual vaccination during pregnancy and their infant feeding strategies. Methods: A cross-sectional study was conducted with 953 Polish mothers. An online questionnaire was used and included questions on sociodemographic and obstetric variables, women’s attitudes towards COVID-19 and influenza vaccination, and breastfeeding practices. Results: COVID-19 vaccination was reported by 66.0%, influenza vaccination by 18.2%, and dual vaccination by 15.6% of Polish mothers. Increasing willingness to receive vaccines was significantly associated with older maternal age, lower BMI, living in urban areas with >100,000 residents, and high levels of knowledge regarding vaccination. No significant association between dual vaccination and neonatal feeding strategy was detected. The group of exclusively breastfeeding mothers, in comparison to formula- and mixed-feeding women, was characterized by having lower pre-pregnancy BMI and previous maternal experience. Conclusions: Rates of vaccination against seasonal influenza and dual (influenza and COVID-19) vaccination remain low among Polish mothers. The promotion of antenatal vaccination and reliable information about short- and long-term advantages related to breastfeeding are crucial to perinatal health care for the mother–infant dyad. Young, primiparous women who are overweight or obese should be targets of preventive programs focused on the health of the mother–infant dyad.


  • Open Access

    Evaluation of Selected Pro- and Anti-Inflammatory Adipokines in Colostrum from Mothers with Gestational Diabetes Mellitus

    by Jolanta Lis-Kuberka, Marta Berghausen-Mazur, Magdalena Orczyk-Pawiłowicz

    Adipokines related to gestational diabetes mellitus (GDM) are an emerging area of interest. The aim of this study was to evaluate the associations between GDM and adipokine levels in human milk. This was an observational cohort study targeting mothers with gestational diabetes, which evaluated the association of maternal hyperglycemia severity, classified as GDM-G1 (diet treatment) and GDM-G2 (insulin treatment), with colostral adipokines involved in pro- and anti-inflammatory processes. Colostrum was collected from hyperglycemic (N = 34) and normoglycemic (N = 26) mothers, and adipokine levels were determined by immunoenzymatic assay. Among anti-inflammatory adipokines, only for irisin and vaspin, but not for obestatin and adropin, were significantly different levels noted between the GDM-G1, GDM-G2 and non-GDM cohorts. Colostrum of the GDM-G2 subgroup contained more vaspin (4.77 ng/mL) than that of normoglycemic mothers (3.12 ng/mL) and more irisin (26.95 μg/mL) than in the GDM-G1 subgroup (17.59 μg/mL). The levels of pro-inflammatory adipokines, namely, dermcidin, chemerin and visfatin, were at similar levels irrespective of maternal glycemia. Moreover, irisin showed a negative correlation with dermcidin in GDM-G2 and non-GDM cohorts. Associations were observed between colostral irisin and maternal preconception BMI, dermcidin and gestational age, and vaspin and maternal age. This study provides evidence that the way of restoring glucose homeostasis in pregnant women has an impact on the anti-inflammatory adipokines irisin and vaspin, but not on obestatin and adropin. GDM, regardless of severity, did not influence the colostral pro-inflammatory adipokines visfatin, chemerin and dermcidin.


  • Open Access

    Gestational Diabetes Mellitus and Colostral Appetite-Regulating Adipokines

    by Jolanta Lis-Kuberka, Marta Berghausen-Mazur, Magdalena Orczyk-Pawiłowicz

    Gestational diabetes mellitus (GDM) is a complex metabolic disorder that has short- and long-term effects on maternal and offspring health. This study aimed to assess the impact of maternal hyperglycemia severity, classified as GDM-G1 (diet treatment) and GDM-G2 (insulin treatment) on colostral appetite-regulating molecules. Colostrum samples were collected from hyperglycemic (N = 30) and normoglycemic (N = 21) mothers, and the concentrations of milk hormones were determined by immunoenzymatic assay. A difference was found for milk ghrelin, but not for molecules such as adiponectin, leptin, resistin, or IGF-I levels, in relation to maternal hyperglycemia. The colostral ghrelin in the GDM-G1 cohort (0.21 ng/mL) was significantly lower than for GDM-G2 (0.38 ng/mL) and non-GDM groups (0.36 ng/mL). However, colostral resistin was higher, but not significantly, for GDM-G1 (13.33 ng/mL) and GDM-G2 (12.81 ng/mL) cohorts than for normoglycemic mothers (7.89 ng/mL). The lack of difference in relation to hyperglycemia for milk leptin, adiponectin, leptin–adiponectin ratio, resistin, and IGF-I levels might be the outcome of effective treatment of GDM during pregnancy. The shift between ghrelin and other appetite-regulating hormones might translate into altered ability to regulate energy balance, affecting offspring’s metabolic homeostasis.


  • Open Access

    The Mother–Child Dyad Adipokine Pattern: A Review of Current Knowledge

    by Jolanta Lis-Kuberka, Małgorzata Pupek, Magdalena Orczyk-Pawiłowicz

    An important role in the network of interconnections between the mother and child is played by adipokines, which are adipose tissue hormones engaged in the regulation of metabolism. Alternations of maternal adipokines translate to the worsening of maternal insulin resistance as well as metabolic stress, altered placenta functions, and fetal development, which finally contribute to long-term metabolic unfavorable conditions. This paper is the first to summarize the current state of knowledge concerning the concentrations of individual adipokines in different biological fluids of maternal and cord plasma, newborn/infant plasma, milk, and the placenta, where it highlights the impact of adverse perinatal risk factors, including gestational diabetes mellitus, preeclampsia, intrauterine growth restriction, preterm delivery, and maternal obesity on the adipokine patterns in maternal–infant dyads. The importance of adipokine measurement and relationships in biological fluids during pregnancy and lactation is crucial for public health in the area of prevention of most diet-related metabolic diseases. The review highlights the huge knowledge gap in the field of hormones participating in the energy homeostasis and metabolic pathways during perinatal and postnatal periods in the mother–child dyad. An in-depth characterization is needed to confirm if the adverse outcomes of early developmental programming might be modulated via maternal lifestyle intervention.


  • Open Access

    Attitude and Level of COVID-19 Vaccination among Women in Reproductive Age during the Fourth Pandemic Wave: A Cross-Sectional Study in Poland

    by Jolanta Lis-Kuberka, Marta Berghausen-Mazur, Magdalena Orczyk-Pawiłowicz

    COVID-19 vaccination, apart from the sanitary regime, is the most efficient strategy to limit the spread of the SARS-CoV-2 virus and significantly reduce the severity of the disease following infection. A cross-sectional survey was conducted during the fourth wave of the COVID-19 pandemic among pregnant Polish women and women who have already given birth to evaluate the level and attitude to vaccination. Briefly, 1196 women (256 pregnant and 940 mothers) participated in the study; 68.0% of pregnant women and 66.2% of mothers declared that they had received COVID-19 vaccination. The most frequently stated reasons not to get vaccinated were possible adverse effects on the mother, fetus or breastfed child, post-vaccination complications and limited scientific evidence on the safety of the COVID-19 vaccine. The identified predictors of avoiding COVID-19 vaccination are young age, residing in small cities or rural areas, cohabitation, low anxiety level regarding SARS-CoV-2 infection, and little knowledge concerning maternal vaccine-induced immune protection delivered to offspring. Despite the unlimited access to COVID-19 vaccination, the declared level of vaccination is worryingly low. The knowledge concerning the benefits of vaccination to mothers and their offspring is not satisfactory and requires urgent educational action, particularly among young women living outside big cities and single motherhood.